TargED Biopharmaceuticals B.V.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Drug Delivery
See more in Biomedtracker

Latest on TargED Biopharmaceuticals B.V.

In Vivo

Pushing Forward: Venture Capitalist Priorities To Accelerate European Biotech

 
• By Jo Shorthouse

Rising Leaders Home In Vivo Rising Leader Thijs Cohen Tervaert is a junior partner at INKEF Capital, having joined the venture capital firm in 2016, he serves on the board of ViCentra B.V. , Aiden

Scrip

TargED Eyes 2024 Clinic Entry For Clot Buster On Back Of Financing

 
• By Ayisha Sharma

TargED Biopharmaceuticals B.V. is aiming for a 2024 clinic entry for its first-in-class clot-busting candidate Microlyse in thrombotic disease after a €39m ($44.3m) Series A financing round. The money